Morphine Sulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Morphine Sulfate Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 10/31/2017.
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-1891-01
- Dosage Form
- Injection
- Presentation
- Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01)
- Initial Posting
- 10/31/2017
- Revised Date